These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 897743)
41. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE. Grennan DM; Ferguson M; Williamson J; Mavrikakis M; Dick WC; Buchanan WW N Z Med J; 1977 Oct; 86(598):374-6. PubMed ID: 272546 [TBL] [Abstract][Full Text] [Related]
42. Distal renal tubular acidosis associated with Sjögren's syndrome. Yasuda K; Sasaki K; Yamato M; Hayashi T Intern Med; 2012; 51(6):675-6. PubMed ID: 22449687 [No Abstract] [Full Text] [Related]
43. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome. Shiozawa S; Tanaka Y; Shiozawa K J Interferon Cytokine Res; 1998 Apr; 18(4):255-62. PubMed ID: 9568728 [TBL] [Abstract][Full Text] [Related]
44. [Sjogren's syndrome and changes in the salivary glands]. Brands T; Schnepper E; Wannenmacher M Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1969 Oct; 53(5):226-33. PubMed ID: 5266064 [No Abstract] [Full Text] [Related]
45. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle. Arisawa H; Fukui K; Fujise N; Masunaga H Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203 [TBL] [Abstract][Full Text] [Related]
50. [Adherence to American European Consensus Group classification criteria for Sjögren's syndrome in differential diagnosis of xerostomia]. Pejda S; Alajbeg I; Alajbeg I Lijec Vjesn; 2011; 133(5-6):180-6. PubMed ID: 21888083 [TBL] [Abstract][Full Text] [Related]
51. [Dermatopolymyositis, Gougerot-Sjögren's syndrome, Hashimoto's thyroiditis and glomerulopathy]. Fain O; Rainfray M; Callard P; Guillevin L; Meyrier A Nephrologie; 1990; 11(4):223-5. PubMed ID: 2074922 [TBL] [Abstract][Full Text] [Related]
52. Optimizing dry mouth treatment for individuals with Sjögren's syndrome. Wu AJ Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418 [TBL] [Abstract][Full Text] [Related]
53. Sjogren's syndrome: oral and dental considerations. Atkinson JC; Fox PC J Am Dent Assoc; 1993 Mar; 124(3):74-6, 78-82, 84-6. PubMed ID: 8335784 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome. Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630 [TBL] [Abstract][Full Text] [Related]
55. Efficient diagnosis of Sjögren's syndrome to reduce the burden on patients. Niikura AJ; Yamachika S; Yamamoto K; Okamoto MR; Ikeda YF; Nakamura S; Oda E; Imamura TK; Saito I; Nakagawa Y Mod Rheumatol; 2015 Jan; 25(1):100-4. PubMed ID: 24919594 [TBL] [Abstract][Full Text] [Related]
57. Primary Sjögren's syndrome (SS) with inappropriate antidiuretic hormone secretion (SIADH). Tanneau R; Pennec YL; Jouquan J; Youinou P; Le Menn G Clin Exp Rheumatol; 1989; 7(5):570-2. PubMed ID: 2591134 [No Abstract] [Full Text] [Related]
58. Renal involvement in Sjögren's syndrome. Bailey RR; Swainson CP N Z Med J; 1986 Aug; 99(807):579-80. PubMed ID: 3462548 [TBL] [Abstract][Full Text] [Related]
59. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome. Miyawaki S; Nishiyama S; Matoba K Intern Med; 1999 Dec; 38(12):938-43. PubMed ID: 10628930 [TBL] [Abstract][Full Text] [Related]
60. Sjögren's syndrome. Adding moisture to your life. Teutsch E; Hill M Am J Nurs; 1987 Mar; 87(3):326-9. PubMed ID: 3644598 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]